Agendia Nabs $23M Series E Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Dutch molecular diagnostics firm Agendia said today that it has raised $23 million in a Series E investment round.

The financing was led by an undisclosed family investment firm that provided approximately half of the funds, Agendia said. In addition, two independent entrepreneurs participated with an investment of US $1 million each, while the remaining capital was raised through Agendia's existing investor base.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.